Stocks
Cara Therapeutics (CARA) EV/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | |||
| EV/EBITDA | ? | 96.8 | -5.15 | -5.16 | 0.14 | 0.15 | -0.50 | |
| Changes by years, y/y, % | -2 111% | -105% | +0% | -103% | +3% | |||
Cara Therapeutics. EV/EBITDA
Cara Therapeutics. EV/EBITDA, changes, %
Cara Therapeutics (CARA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | -0.17 | 0.14 | 0.15 | -0.21 | -0.04 | -0.50 | |
| Changes by years, y/y, % | -96% | -103% | -103% | -88% | -92% | |||
| Changes by quarters, q/q, % | -68% | -185% | +4% | -243% | -79% | |||
